Live Agbiotech updates | Page 12
Live Agbiotech news coverage of developments with the latest updates. Stay on top of latest Agbiotech news stories and find out what just happened, what is going on with Agbiotech. The latest real-time news updates and headlines on Agbiotech
Mission to BioKorea to strengthen ties
21 Apr 2022 2:34 pm AEST
EpiAxis Therapeutics appoints new chief science officer
19 Apr 2022 2:16 pm AEST
Zelria Therapeutics executes acquisition of Health House
19 Apr 2022 2:16 pm AEST
Botanix confirms presentation of data at upcoming congress
14 Apr 2022 2:16 pm AEST
Imugene says first cohort two patient dose in phase 1 clinical trial
14 Apr 2022 2:16 pm AEST
Microbio is step closer to launching its InfectID-BSI tests in Europe
12 Apr 2022 3:09 pm AEST
Rhonomed completes institutional component of capital raise
12 Apr 2022 3:09 pm AEST
Australian Pavilion returns in-person to BIO 2022
12 Apr 2022 2:12 pm AEST
MTPConnect announces support for major new resilience projects
07 Apr 2022 2:36 pm AEST
Race receives human ethics approval for new trial
07 Apr 2022 2:36 pm AEST
Microba announces new research partnership and senior appointment
05 Apr 2022 2:26 pm AEST
Australian healthcare investor urges greater support from peers
05 Apr 2022 2:18 pm AEST
Avecho reports positive results for Phase 2 topical CBD osteoarthritis study
01 Apr 2022 9:34 am AEDT
NTCELL to be produced in Australia under UTS research agreement
01 Apr 2022 8:46 am AEDT
Government launches biotechnology - strategic plan for health and medicine
31 Mar 2022 2:18 pm AEDT
Dimerix receives R&D tax rebate for last financial year
29 Mar 2022 2:24 pm AEDT
Neuren receives FDA approval for Pitt Hopkins IND and Phase 2 trial
29 Mar 2022 2:24 pm AEDT
BioScience Managers welcomes FDA approval of Saluda technology
24 Mar 2022 2:14 pm AEDT
Large molecule facility doubles size of leading bioanalytical laboratory
24 Mar 2022 2:14 pm AEDT
Industry concerned by leaked Covid vaccine IP waiver text
24 Mar 2022 2:05 pm AEDT
Biotron updates on pre-clinical study of BIT225 in Covid
22 Mar 2022 3:16 pm AEDT
US FDA grants new orphan designation to Noxopharm's Veyonda
22 Mar 2022 3:16 pm AEDT
Access savings by registering early for AusMedtech 2022
22 Mar 2022 2:21 pm AEDT
Paradigm secures UK approvals for PARA_OA_002 clinical trial
17 Mar 2022 4:28 pm AEDT
First Participants dosed in ENA Respiratory's phase 2a study
17 Mar 2022 4:20 pm AEDT
WA funding programmes open
17 Mar 2022 4:11 pm AEDT
Neuren receives ethics approval for Angelman Phase 2 trial
16 Mar 2022 8:22 am AEDT
'Gold standard' commercialisation for biotech
16 Mar 2022 8:06 am AEDT
Partnership encourages innovation in how Australian universities and industry collaborate
14 Mar 2022 5:46 am AEDT
Telix's ZIRCON late-stage kidney cancer imaging study completes enrolment
11 Mar 2022 11:58 am AEDT
Rebrand for Australia's largest life sciences venture fund
11 Mar 2022 11:58 am AEDT
Victoria's Medtech Manufacturing Capability Programme opens
11 Mar 2022 11:43 am AEDT
Recognition for Vetter in CMO Leadership Awards
08 Mar 2022 3:50 pm AEDT
Chimeric Therapeutics announces final results from Phase 1 trial of CORE NK Platform
08 Mar 2022 3:50 pm AEDT
International Women's Day: AusBiotech 'moving dial' on gender equity
08 Mar 2022 3:02 pm AEDT
Antisense Therapeutics confirms ATL1102 poster presentation
04 Mar 2022 8:42 am AEDT
New expedited regulatory pathway proposed for novel biologicals
04 Mar 2022 8:18 am AEDT
Approval for Neuren Pharmaceuticals' Phase 2 trial in Angelman syndrome
02 Mar 2022 1:04 pm AEDT
Patrys selects stable cell line for production of PAT-DX3
02 Mar 2022 12:48 pm AEDT
Lucy Turnbull AO rejoins board of Immutep
02 Mar 2022 12:23 pm AEDT
AusBiotech highlights clarity and transparency is key in recent submissions
02 Mar 2022 11:51 am AEDT
Kazia Therapeutics to be 'transformed' by pipeline progress
25 Feb 2022 10:48 am AEDT
New award recognises industry's role in clinical trials
25 Feb 2022 10:09 am AEDT
Arovella Therapeutics closes over-subscribed share purchase plan
23 Feb 2022 9:34 am AEDT
Important support programme oversubscribed
23 Feb 2022 9:01 am AEDT
Amplia says new report 'paves way' for its phase 2 trial
18 Feb 2022 10:28 am AEDT
Engage early on reimbursement and regulation strategies
18 Feb 2022 10:05 am AEDT
Vaccine developer Sementis appoints chief operating officer
15 Feb 2022 2:28 pm AEDT